NIGHTSTAR THERAPEUTICS PLC Operating Expenses
NIGHTSTAR THERAPEUTICS PLC reported Operating Expenses of $18.56 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-05-10
- NIGHTSTAR THERAPEUTICS PLC operating expenses for the quarter ending 2019-03-31 was $18.56M, a 109.97% increase year-over-year.
- NIGHTSTAR THERAPEUTICS PLC operating expenses for the quarter ending 2018-12-31 was $13.08M, a 5.21% decline year-over-year.
- NIGHTSTAR THERAPEUTICS PLC operating expenses for the quarter ending 2018-09-30 was $10.86M, a 80.83% increase year-over-year.
- NIGHTSTAR THERAPEUTICS PLC operating expenses for the quarter ending 2018-06-30 was $11.38M, a 169.64% increase year-over-year.
- NIGHTSTAR THERAPEUTICS PLC operating expenses for fiscal 2018 was $44.16M, a 60.55% increase from fiscal 2017.
- NIGHTSTAR THERAPEUTICS PLC operating expenses for fiscal 2017 was $27.50M, a 125.07% increase from fiscal 2016.
- NIGHTSTAR THERAPEUTICS PLC operating expenses for fiscal 2016 was $12.22M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-03-31 | $18.56M 10-Q · filed 2019-05-10 | $31.64M derived: sum of 2 quarters · filed 2019-05-10 | $42.50M derived: sum of 3 quarters · filed 2019-05-10 | $53.88M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | $13.08M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $23.94M derived: sum of 2 quarters · filed 2019-03-18 | $35.32M derived: sum of 3 quarters · filed 2019-03-18 | $44.16M 10-K · filed 2019-03-18 |
| 2018-09-30 | $10.86M 6-K · filed 2018-11-20 | $22.24M derived: sum of 2 quarters · filed 2018-11-20 | $31.08M 6-K · filed 2018-11-20 | $44.88M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-06-30 | $11.38M 6-K · filed 2018-08-15 | $20.22M 6-K · filed 2018-08-15 | $34.01M derived: sum of 3 quarters · filed 2019-05-10 | $40.02M derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-03-31 | $8.84M 10-Q · filed 2019-05-10 | $22.64M derived: sum of 2 quarters · filed 2019-05-10 | $28.64M derived: sum of 3 quarters · filed 2019-05-10 | $32.86M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $13.80M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $19.80M derived: sum of 2 quarters · filed 2019-03-18 | $24.02M derived: sum of 3 quarters · filed 2019-03-18 | $27.50M 10-K · filed 2019-03-18 |
| 2017-09-30 | $6.01M 6-K · filed 2018-11-20 | $10.23M derived: sum of 2 quarters · filed 2018-11-20 | $13.71M 6-K · filed 2018-11-20 | |
| 2017-06-30 | $4.22M 6-K · filed 2018-08-15 | $7.70M 6-K · filed 2018-08-15 | ||
| 2016-12-31 | $12.22M 10-K · filed 2019-03-18 | |||
| 2015-12-31 | $9.32M 20-F · filed 2018-04-03 |